San Diego-based mostly Viking Therapeutics marked alone as a significant competitor inside the weight loss drug current market in February right after revealing promising facts from a mid-stage trial of experimental drug VK2735, which prompt it rivaled—and outperformed—Novo and Lilly drugs when given as being a weekly injection and in March the